Skip to content

Clinical trials

Phase 2 Central Nervous System Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Neoplasms Phase: Phase 2 Country / region: Canada Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20011
20023
20032
20041
20051
20061
20091
20101
20171
20181
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Active, not recruiting3
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group9
National Cancer Institute (NCI)7
Radiation Therapy Oncology Group5
Children's Hospital Los Angeles2
NCIC Clinical Trials Group2
Duke University1
Memorial Sloan Kettering Cancer Center1
Miltenyi Biomedicine GmbH1
NYU Langone Health1
Ottawa Regional Cancer Centre1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Neoplasms33
Brain Neoplasms14
Astrocytoma13
Medulloblastoma10
Oligodendroglioma10
Glioma8
Neuroblastoma7
Sarcoma7
Optic Nerve Glioma6
Glioblastoma5

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.